Get the Stockscreener App
161.64
0.65%
-1.05
After Hours:
163.63
1.99
+1.23%
Ishares Biotechnology Etf stock is traded at $161.64, with a volume of 1.42M.
It is down -0.65% in the last 24 hours and down -8.35% over the past month.
See More
Previous Close:
$162.69
Open:
$161.34
24h Volume:
1.42M
Relative Volume:
0.78
Market Cap:
$9.09B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-3.31%
1M Performance:
-8.35%
6M Performance:
+14.12%
1Y Performance:
+19.46%
1-Day Range:
$159.68
$162.38
1-Week Range:
$159.68
$166.81
52-Week Range:
$107.43
$179.64
Ishares Biotechnology Etf Stock (IBB) Company Profile
Name
Ishares Biotechnology Etf
Sector
Industry
Phone
-
Address
-
Compare IBB vs VTI, SPY, IVV, VB, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IBB
Ishares Biotechnology Etf
|
161.64 | 9.09B | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
323.18 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
State Street Spdr S P 500 Etf Trust
|
653.18 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
656.23 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
263.51 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
583.98 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares Biotechnology Etf Stock (IBB) Latest News
DAFNA Capital Sells iShares Biotech ETF Shares: Portfolio Impact & ETF FocusNews and Statistics - IndexBox
DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing - AOL.com
DAFNA Capital Reduces Holdings in iShares Biotechnology ETF as Part of Overall Biotech Portfolio Adjustment, Recent SEC Filing Shows - Bitget
iShares NASDAQ Biotechnology ETF declares quarterly distribution of $0.1218 - MSN
Clearance etf indice biotecnologie nasdaq Deals Como operar com o indice NASDAQ Investimento em NASDAQ LiteFinance - маяк32.рф
Is Relay Therapeutics a Buy in 2026? One Institutional Investor Just Made a $6 Million Bet. - The Motley Fool
iShares Biotechnology ETF Estimated Cash Index OverviewStock Price, Quote and News - marketscreener.com
Bank of America Corp DE Lowers Holdings in iShares Biotechnology ETF $IBB - Defense World
Beyond Tech Industry: Here's how Biotech ETFs Are Riding the AI Wave - TradingView
Biotech ETF With A Twist: Defiance To Donate Initial Advisory Profits To Autism Causes - Benzinga
SOXXBlackRock Announces Product Updates to Two iShares ETFs - mx.advfn.com
Aster Capital Management DIFC Ltd Makes New Investment in iShares Biotechnology ETF $IBB - Defense World
iShares Nasdaq Biotechnology ETF declares quarterly distribution of $0.0828 - MSN
7 Best Healthcare ETFs for Long-Term Investors - Coinpaper
How to Buy iShares Biotechnology ETF (IBB) - The Motley Fool
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - Yahoo Finance
Merit Financial Group LLC Trims Stock Holdings in iShares Biotechnology ETF $IBB - Defense World
Caprock Group LLC Takes Position in iShares Biotechnology ETF $IBB - Defense World
XBI vs. IBB: Which Biotech ETF do Analysts Prefer in 2026? - TipRanks
Should You Invest in the iShares Biotechnology ETF (IBB)? - Yahoo Finance
Top ETFs Tracking CRISPR Gene Editing for 2026 - The Motley Fool
Reasons the Biotech Sector Might Be Shifting and the Implications of the iShares Biotechnology ETF (IBB) - Intellectia AI
Biotech in Flux: Patent Cliff and IPO Revival Shape the IBB - AD HOC NEWS
7 Best Biotech ETFs to Buy Now | Investing | U.S. News - US News Money
Biotech ETF Recommended, Amcor Reports Strong Earnings - Intellectia AI
Best Biotech ETFs to Buy in 2026 - The Motley Fool
Amcor, Emerson Electric And More: CNBC's 'Final Trades' - Benzinga
Biotechnology Sector Faces Headwinds as Key ETF Navigates Challenges - AD HOC NEWS
6 Best Health Care Funds and ETFs to Buy Now - US News Money
Florin Court Capital LLP Makes New Investment in iShares Biotechnology ETF $IBB - Defense World
This Wealth Manager Just Dumped Its Entire $3.5 Million Stake in the iShares Biotech ETF - AOL.com
IBB: Beyond The 2025 Surge, Biotech Breakout (NASDAQ:IBB) - Seeking Alpha
IBB: Biotech's Hot Streak May Cool (NASDAQ:IBB) - Seeking Alpha
2 Under-the-Radar Biotech Stocks Set to Boom in 2026 - The Motley Fool
Health Care Stocks Steady, iShares Biotechnology ETF Inactive - Intellectia AI
Triple-Leveraged Biotech ETF Doubles as Regulatory Winds Shift in 2026 - 24/7 Wall St.
Nvidia–Eli Lilly Tie-Up Shows Why AI Drug Discovery Is The Next ETF Battleground - Benzinga
SG Americas Securities LLC Has $4.13 Million Stock Position in iShares Biotechnology ETF $IBB - Defense World
A Tale of Two Biotechs: Stability and Speculation in the ETF Arena - AD HOC NEWS
D.A. Davidson & CO. Increases Stock Position in iShares Biotechnology ETF $IBB - Defense World
Here's Why Biotech ETFs Are Rallying Hard - Yahoo Finance
Head-To-Head Survey: iShares Biotechnology ETF (NASDAQ:IBB) vs. Nuveen New York Municipal Valu (NYSE:NNY) - Defense World
As AI Valuations Stretch, Health Care ETFs Step Into The Growth Spotlight - Benzinga
Ishares Biotechnology Etf Stock (IBB) Financials Data
There is no financial data for Ishares Biotechnology Etf (IBB). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.55%
1.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):